News & Events
Read our recent press releases and follow Vascudyne’s newest advancements
Regenerative Medicine Company Vascudyne Relocates to High Capacity GMP Manufacturing Facility
Vascudyne announces its relocation from Stillwater to St. Paul, Minnesota. The new 15,000 sq. ft. facility includes recently remodeled manufacturing, warehouse, laboratory, and office spaces.
The relocation is particularly driven by the addition of a dedicated 5,000 sq. ft. ISO 7 Cleanroom manufacturing facility that is critical for the support of ongoing clinical studies. Vascudyne’s product development pipeline of cardiovascular grafts, valves, and patches as well as other soft tissue applications with unmet clinical needs is poised to benefit from the expanded research and development space and cleanroom capabilities.
St. Paul, Minnesota, is also located in the epicenter of Medical Alley, the Silicon Valley of Healthcare, and Vascudyne’s new location enables increased interactions with the Twin Cities medtech ecosystem, employment opportunities for local talent, and ability to meet growing global demand for our products.
Address
Social Media
These are investigational uses that have not been approved by any health authority. Safety and efficacy have not been established and there is no guarantee that pipeline products or investigational uses will receive approval from health authorities.
Copyright 2025 | Vascudyne, Inc.
